- Home
- ANIX vs LRE Comparison
ANIX vs LRE Comparison
Compare ANIX & LRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIX
- LRE
- Stock Information
- Founded
- ANIX 1982
- LRE 2001
- Country
- ANIX United States
- LRE Japan
- Employees
- ANIX N/A
- LRE N/A
- Industry
- ANIX Biotechnology: Pharmaceutical Preparations
- LRE
- Sector
- ANIX Health Care
- LRE
- Exchange
- ANIX Nasdaq
- LRE Nasdaq
- Market Cap
- ANIX 101.4M
- LRE 19.2M
- IPO Year
- ANIX 1987
- LRE 2023
- Fundamental
- Price
- ANIX $3.08
- LRE $1.59
- Analyst Decision
- ANIX Strong Buy
- LRE
- Analyst Count
- ANIX 2
- LRE 0
- Target Price
- ANIX $8.50
- LRE N/A
- AVG Volume (30 Days)
- ANIX 42.0K
- LRE 8.7K
- Earning Date
- ANIX 10-29-2024
- LRE 01-01-0001
- Dividend Yield
- ANIX N/A
- LRE N/A
- EPS Growth
- ANIX N/A
- LRE N/A
- EPS
- ANIX N/A
- LRE 0.25
- Revenue
- ANIX N/A
- LRE $118,414,146.00
- Revenue This Year
- ANIX N/A
- LRE N/A
- Revenue Next Year
- ANIX N/A
- LRE N/A
- P/E Ratio
- ANIX N/A
- LRE $6.44
- Revenue Growth
- ANIX N/A
- LRE 14.65
- 52 Week Low
- ANIX $2.15
- LRE $1.19
- 52 Week High
- ANIX $5.13
- LRE $13.76
- Technical
- Relative Strength Index (RSI)
- ANIX 41.08
- LRE 50.50
- Support Level
- ANIX $2.95
- LRE $1.51
- Resistance Level
- ANIX $3.11
- LRE $1.71
- Average True Range (ATR)
- ANIX 0.12
- LRE 0.09
- MACD
- ANIX -0.01
- LRE 0.00
- Stochastic Oscillator
- ANIX 19.35
- LRE 45.34
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc, a cancer-focused biotechnology company, developing vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.
About LRE Lead Real Estate Co. Ltd
Lead Real Estate Co Ltd operates as a developer of luxury residential properties, including single-family homes and condominiums, across Tokyo and Kanagawa prefecture. It operates hotels in Tokyo and leases apartment building units to individual customers in Japan and Dallas, Texas. It generates revenue from developing and selling single-family homes and condominiums. The company's primary and sole operating segment is real estate sales.